KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CareDx (CDNA) Other Operating Expenses (2016 - 2025)

Historic Other Operating Expenses for CareDx (CDNA) over the last 13 years, with Q2 2025 value amounting to -$350000.0.

  • CareDx's Other Operating Expenses changed N/A to -$350000.0 in Q2 2025 from the same period last year, while for Sep 2025 it was -$52.7 million, marking a year-over-year decrease of 13715.89%. This contributed to the annual value of $95.0 million for FY2024, which is 6625.11% down from last year.
  • As of Q2 2025, CareDx's Other Operating Expenses stood at -$350000.0.
  • Over the past 5 years, CareDx's Other Operating Expenses peaked at $141.9 million during Q4 2023, and registered a low of -$47.0 million during Q4 2024.
  • For the 5-year period, CareDx's Other Operating Expenses averaged around $40.8 million, with its median value being $47.5 million (2023).
  • Per our database at Business Quant, CareDx's Other Operating Expenses skyrocketed by 16696.26% in 2023 and then tumbled by 13313.53% in 2024.
  • Over the past 5 years, CareDx's Other Operating Expenses (Quarter) stood at $47.8 million in 2021, then rose by 11.15% to $53.2 million in 2022, then surged by 166.96% to $141.9 million in 2023, then plummeted by 133.14% to -$47.0 million in 2024, then soared by 99.26% to -$350000.0 in 2025.
  • Its last three reported values are -$350000.0 in Q2 2025, -$5.4 million for Q1 2025, and -$47.0 million during Q4 2024.